Skip to search formSkip to main contentSkip to account menu

Dacarbazine/Dactinomycin/Vincristine

Known as: AVD, DACT/DTIC/VCR 
National Institutes of Health

Related topics

Related topics

3 relations
DacarbazineDactinomycinVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Sensor based healthcare information system
Over the last few years, the convincing forward steps in the development of Internet of Things (IoT)-enabling solutions are… 
2015
2015
Brentuximab vedotin plus AVD for non-bulky limited stage Hodgkin lymphoma: A phase II trial.
8505 Background: ABVD plus radiation is standard therapy for limited HL, but carries risks of bleomycin-lung injury and radiation… 
2011
2011
Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells
Cisplatin-based chemotherapy is the standard therapy used to treat non-small-cell lung cancer. However, its efficacy is largely… 
2011
2011
Improved Efficacy Upon Combined JAK1/2 and Pan-Deacetylase Inhibition Using Ruxolitinib (INC424) and Panobinostat (LBH589) in Preclinical Mouse Models of JAK2V617F-Driven Disease
Abstract 798 Background: Ruxolitinib (INC424), a potent and selective oral JAK1 and JAK2 inhibitor, has demonstrated rapid and… 
2011
2011
Persistance à long terme des anticorps neutralisants de la fièvre jaune chez les personnes âgées de 60 ans et plus
RésuméAvec la réapparition de zones d’activité du virus amarile dans le nord de l’Argentine ou le Paraguay et la persistance de… 
Review
2011
Review
2011
The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma
In recent decades, the prognosis of Hodgkin lymphoma has been substantially improved, but these successes have been restricted to… 
Review
2008
Review
2008
Yellow fever-associated viscerotropic disease in Barcelona, Spain.
Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever… 
1992
1992
Total sympathetic activity and atrial natriuretic factor levels in VVI and DDD pacing with different atrioventricular delays during daily activity and exercise.
The purpose of the study was to assess at rest and during exercise total sympathetic activity, as expressed by plasma cyclic AMP… 
1988
1988
A New Algorithm for a High Level of Protection Against Pacemaker‐Mediated Tachycardia
Pacemaker‐mediated tachycardia (PMT) is a well‐known complication of DDD pacing. PMT needs a permeable V‐A conduction and is… 
1976
1976
Pentobarbital elimination in patients with poor renal function
Drug oxidation is slowed in experimental uremia in animals but has been reported to be normal or accelerated in uremic patients… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)